Subscribe To
Arnault drops us$11bn as luxury goods worries spark lvmh sell-off
Bernard Arnault, currently the world's richest man according to the Bloomberg Billionaires Index, might be about to lose that title again after shares...
May 24, 2023, 3:38 am
Ironwood (irwd) to acquire vectivbio for $1b, stock up 3.6%
Ironwood (IRWD) offers to acquire VectivBio, which will help strengthen its gastrointestinal treatment portfolio....
May 23, 2023, 1:09 pm
7 hills pharma surpasses $25mm milestone in nondilutive funding
HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) — 7 Hills Pharma LLC (“7 Hills” or “7HP”) announced today that it has been awarded $13.5MM in nondilu...
May 22, 2023, 5:05 pm
Meta hit with record £1bn fine
The owner of WhatsApp, Instagram and Facebook has been slapped with a record fine of €1.2bn (£1.04bn) by the Irish data protection regulator....
May 22, 2023, 5:25 am
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:05 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic
8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...
May 21, 2023, 8:00 pm
Disney scraps plan for us$1bln campus
The Walt Disney Company (NYSE:DIS) is cancelling plans to build an almost US$1bln corporate campus in c...
May 19, 2023, 8:11 am
Royal mail needs ai, but its implementation won't be easy
Royal Mail's depressing year was compounded with today's £1bn loss, and while times look tough for the...
May 18, 2023, 9:14 am
Royal mail owner, ids, swings into red as strike action eats into profits
International Distributions Services PLC (LSE:IDS) swung into the red as strike action at Royal Mail saw reported losses at its postal delivery arm to...
May 18, 2023, 2:36 am
Pfizer (pfe) to raise $31b in debt to fund seagen (sgen) deal
Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN)....
May 17, 2023, 11:17 am
Manchester united gets "fergie time" improved bid as qatari sheikh pushes for control
The race to buy Manchester United has taken another twist after Sheikh Jassim bin Hamad al-Thani made a dramatic fourth bid for the Red Devils, accor...
May 17, 2023, 6:25 am
Fx option expiries for 17 may 10am new york cut
EUR/USD- 1.0795-10 (€751m)- 1.0825-35 (€556m)- 1.0915-20 (€619m)USD/JPY- 134.50 ($2.1bn)- 135.50 ...
May 17, 2023, 4:20 am
Google, meta, amazon hire low-paid foreign workers after us layoffs: report
H-1b visas have been a lightning rod in the immigration debate, with critics saying they are used to un...
May 16, 2023, 3:43 pm
Wells fargo to pay $1b to settle shareholder lawsuit over slew of scandals
Wells Fargo has agreed to pay $1 billion to avoid the burden and expense of going to trial over a lawsuit where shareholders claimed the bank overstat...
May 16, 2023, 1:46 pm